JPRN-UMIN000021623已完成未知
Effects of ipragliflozin on body composition and beta-cell function in Japanese patients with type 2 diabetes - Effects of ipragliflozin on body composition and beta-cell function
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria were pregnancy, severe illness, CKD (eGFR < 60 ml/min/1.73m2), and malignancy.
研究者
相似试验
招募中
不适用
Effects of Ipragliflozin on Body Composition in Type 1 Diabetic Patientstype 1 diabetic patientsJPRN-UMIN000036039Ise Red Cross Hospital Department of Metabolic Diseases50
已完成
不适用
Effects of Ipragliflozin on Body Weight in Japanese Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Insulin TherapyType 2 diabetesJPRN-UMIN000018839Shiga University of Medical Science50
已完成
不适用
Effects of ipragliflozin on nonalcoholic fatty liver disease in patients with type 2 diabetesType 2 diabetes with nonalcoholic fatty liver diseaseJPRN-UMIN000022651Ogawa Red Cross Hospital60
Unknown
4 期
Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRDESRDNCT01253928Centre Hospitalier Universitaire Vaudois16
招募中
4 期
Comparison of old anti-diabetic drugs Pioglitazone and Glimepiride in Indian patients, which one is better in terms of improvement of underlying cause of disease.CTRI/2023/09/057166Professor and Head department of Endocrinology